For patients with MCI associated with Alzheimer disease, those in the highest tertile of the triglyceride-glucose index experience faster cognitive decline.

Cognito Therapeutics has reached its enrolment goal for the randomised, sham-controlled HOPE Study investigating the Spectris ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

A new tool developed by researchers can estimate how fast someone is aging by analyzing a single MRI brain scan, predicting ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

The study, published in the Journal of Clinical Sleep Medicine, found that lower levels of REM and slow-wave sleep were ...

Hiding deep inside the body, a dangerous type of fat wraps itself around vital organs such as the kidneys, liver and heart — ...

It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled to try the new drugs. A single register of those with the disease would also ...